{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:00:18Z","timestamp":1794294018234,"version":"4.9.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grifols"}],"content-domain":{"domain":["autonomicneuroscience.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autonomic Neuroscience"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.autneu.2020.102668","type":"journal-article","created":{"date-parts":[[2020,3,23]],"date-time":"2020-03-23T12:22:19Z","timestamp":1584966139000},"page":"102668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Treatment induced neuropathy of diabetes"],"prefix":"10.1016","volume":"226","author":[{"given":"Christopher H.","family":"Gibbons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.autneu.2020.102668_bb0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.autneu.2020.102668_bb0010","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1001\/archinte.1983.00350100195040","article-title":"Diabetic neuropathic cachexia. Report of a woman with this syndrome and review of the literature","volume":"143","author":"Blau","year":"1983","journal-title":"Arch.Intern.Med."},{"key":"10.1016\/j.autneu.2020.102668_bb0015","first-page":"745","article-title":"Insulin neuritis: a case report","volume":"59","author":"Caravati","year":"1933","journal-title":"Va.Med.Monthly"},{"key":"10.1016\/j.autneu.2020.102668_bb0020","series-title":"National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011","author":"CDC","year":"2011"},{"issue":"5","key":"10.1016\/j.autneu.2020.102668_bb0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000071355","article-title":"Reversion of 'early worsening' of diabetic retinopathy by deliberate restoration of poor metabolic control","volume":"217","author":"Chantelau","year":"2003","journal-title":"Ophthalmologica"},{"issue":"4","key":"10.1016\/j.autneu.2020.102668_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000260231","article-title":"Downregulation of serum IGF-1 for treatment of early worsening of diabetic retinopathy: a long-term follow-up of two cases","volume":"224","author":"Chantelau","year":"2010","journal-title":"Ophthalmologica"},{"issue":"7","key":"10.1016\/j.autneu.2020.102668_bb0035","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc14-2646","article-title":"Eating disorders in girls and women with type 1 diabetes: a longitudinal study of prevalence, onset, remission, and recurrence","volume":"38","author":"Colton","year":"2015","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.autneu.2020.102668_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.biopha.2008.08.011","article-title":"Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients","volume":"63","author":"Dabby","year":"2009","journal-title":"Biomed. Pharmacother."},{"issue":"6471","key":"10.1016\/j.autneu.2020.102668_bb0045","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.290.6471.811","article-title":"Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study","volume":"290","author":"Dahl-Jorgensen","year":"1985","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"4","key":"10.1016\/j.autneu.2020.102668_bb0050","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-2007-970577","article-title":"Early retinopathy progression in four randomized trials comparing insulin glargine and NPH insulin","volume":"115","author":"Davis","year":"2007","journal-title":"Exp.Clin.Endocrinol.Diabetes"},{"key":"10.1016\/j.autneu.2020.102668_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/diab.23.5.418","article-title":"Diabetic neuropathic cachexia","volume":"23","author":"Ellenberg","year":"1974","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.autneu.2020.102668_bb0060","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jama.1980.03300370034023","article-title":"Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine","volume":"243","author":"Gade","year":"1980","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.autneu.2020.102668_bb0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jdiacomp.2017.01.010","article-title":"Treatment induced neuropathy of diabetes-long term implications in type 1 diabetes","volume":"31","author":"Gibbons","year":"2017","journal-title":"J. Diabetes Complicat."},{"issue":"4","key":"10.1016\/j.autneu.2020.102668_bb0070","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ana.21952","article-title":"Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy","volume":"67","author":"Gibbons","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.autneu.2020.102668_bb0075","doi-asserted-by":"crossref","unstructured":"Gibbons, C. H. and R. Freeman (2015). \"Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.\" Brain 138(Pt 1): 43\u201352.","DOI":"10.1093\/brain\/awu307"},{"issue":"11","key":"10.1016\/j.autneu.2020.102668_bb0080","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2012.06.030","article-title":"Experimental hypoglycemia is a human model of stress-induced hyperalgesia","volume":"153","author":"Gibbons","year":"2012","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.autneu.2020.102668_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/jns5.12021","article-title":"The evolving natural history of neurophysiologic function in patients with well-controlled diabetes","volume":"18","author":"Gibbons","year":"2013","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"7","key":"10.1016\/j.autneu.2020.102668_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1037\/a0040408","article-title":"Psychological conditions in adults with diabetes","volume":"71","author":"de Groot","year":"2016","journal-title":"Am Psychol"},{"issue":"14","key":"10.1016\/j.autneu.2020.102668_bb0095","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"Group","year":"1993","journal-title":"N.Engl.J Med."},{"issue":"7","key":"10.1016\/j.autneu.2020.102668_bb0100","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archopht.116.7.874","article-title":"Early worsening of diabetic retinopathy in the diabetes control and complications trial","volume":"116","author":"Group","year":"1998","journal-title":"Arch. Ophthalmol."},{"issue":"12","key":"10.1016\/j.autneu.2020.102668_bb0105","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2337\/diacare.22.12.1944","article-title":"Progression of retinopathy after improved metabolic control in type 2 diabetic patients. Relation to IGF-1 and hemostatic variables","volume":"22","author":"Henricsson","year":"1999","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.autneu.2020.102668_bb0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/2042018810391900","article-title":"Clinical approach to the treatment of painful diabetic neuropathy","volume":"2","author":"Hovaguimian","year":"2011","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"6 Pt 1","key":"10.1016\/j.autneu.2020.102668_bb0115","first-page":"E980","article-title":"Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve","volume":"266","author":"Kihara","year":"1994","journal-title":"Am.J.Physiol"},{"issue":"3","key":"10.1016\/j.autneu.2020.102668_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/1573399811309030007","article-title":"Insulin neuritis and diabetic cachectic neuropathy: a review","volume":"9","author":"Knopp","year":"2013","journal-title":"Curr. Diabetes Rev."},{"issue":"6","key":"10.1016\/j.autneu.2020.102668_bb0125","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM198408093110604","article-title":"Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial","volume":"311","author":"Kroc Collaborative Study","year":"1984","journal-title":"N. Engl. J. Med."},{"issue":"8318","key":"10.1016\/j.autneu.2020.102668_bb0130","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(83)92585-0","article-title":"Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics","volume":"1","author":"Lauritzen","year":"1983","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.autneu.2020.102668_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/ceo.13393","article-title":"Early worsening of diabetic retinopathy due to intensive glycaemic control","volume":"47","author":"Lim","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.autneu.2020.102668_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00685978","article-title":"Acute painful diabetic neuropathy precipitated by strict glycemic control","volume":"72","author":"Llewelyn","year":"1986","journal-title":"Acta Neuropathol.(Berl)"},{"issue":"9","key":"10.1016\/j.autneu.2020.102668_bb0145","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2337\/diacare.11.9.748","article-title":"Acute painful diabetic neuropathy","volume":"11","author":"Llewelyn","year":"1988","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.autneu.2020.102668_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02581190","article-title":"Diabetic neuropathic cachexia and diabetic amyotrophy","volume":"19","author":"Massey","year":"1982","journal-title":"Acta Diabetol.Lat."},{"key":"10.1016\/j.autneu.2020.102668_bb0155","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2017.04.036","article-title":"Murine model and mechanisms of treatment-induced painful diabetic neuropathy","volume":"354","author":"Nicodemus","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.autneu.2020.102668_bb0160","doi-asserted-by":"crossref","first-page":"g1799","DOI":"10.1136\/bmj.g1799","article-title":"Painful diabetic neuropathy","volume":"348","author":"Peltier","year":"2014","journal-title":"BMJ"},{"issue":"22","key":"10.1016\/j.autneu.2020.102668_bb0165","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1161\/CIRCULATIONAHA.108.837369","article-title":"Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study (DCCT\/EDIC)","volume":"119","author":"Pop-Busui","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.autneu.2020.102668_bb0170","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11892-010-0120-8","article-title":"DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history","volume":"10","author":"Pop-Busui","year":"2010","journal-title":"Curr.Diab.Rep."},{"issue":"3","key":"10.1016\/j.autneu.2020.102668_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00418349","article-title":"Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis)","volume":"39","author":"Tesfaye","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.autneu.2020.102668_bb0180","doi-asserted-by":"crossref","first-page":"l982","DOI":"10.1136\/bmj.l982","article-title":"Diabulimia: the world\u2019s most dangerous eating disorder","volume":"364","author":"Torjesen","year":"2019","journal-title":"BMJ"}],"container-title":["Autonomic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070219302292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1566070219302292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:13:45Z","timestamp":1761567225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1566070219302292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"alternative-id":["S1566070219302292"],"URL":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102668","relation":{},"ISSN":["1566-0702"],"issn-type":[{"value":"1566-0702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment induced neuropathy of diabetes","name":"articletitle","label":"Article Title"},{"value":"Autonomic Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autneu.2020.102668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102668"}}